VANCOMYCIN MODIFICATION
ID: SPE2D217D0059P00005Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

Original Source

https://sam.gov/opp/c053567b91f64bce80f8837aaedd0f2f/view
Timeline
    Description

    Special Notice DEPT OF DEFENSE is seeking VANCOMYCIN MODIFICATION services. VANCOMYCIN MODIFICATION P00005 is a contract modification that incorporates additional clauses into the existing contract. VANCOMYCIN is an antibiotic used to treat serious bacterial infections. The DEPT OF DEFENSE is looking to modify the contract to include these additional clauses.

    Files
    Title
    Posted
    SPE292-17-D-0059 P0006 signed.pdf
    SPE2D217D0059P00005 SIGNED.pdf
    SPE2D217D0059P00007.pdf
    SPE2D217D0059P00008 signed.pdf
    Lifecycle
    Title
    Type
    VANCOMYCIN MODIFICATION
    Currently viewing
    Special Notice
    Similar Opportunities
    Fluconazole - Modification P00005 to Contract
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY - TROOP SUPPORT MEDICAL is seeking a modification to the contract for Fluconazole. Fluconazole is a medication used to treat and prevent fungal infections. The modification, P00005, will involve changing the National Drug Codes (NDCs) associated with the procurement.
    LANSOPRAZOLE NATIONAL CONTRACT MODIFICATION
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE - DEFENSE LOGISTICS AGENCY is issuing a modification to the LANSOPRAZOLE NATIONAL CONTRACT. This modification aims to incorporate additional clauses to the existing contract. Lansoprazole is a medication used to treat stomach and esophagus problems such as acid reflux, ulcers, and gastroesophageal reflux disease (GERD). It belongs to a class of drugs known as proton pump inhibitors and helps reduce the amount of acid produced in the stomach. The modification to the contract will include the addition of specific clauses that may address various aspects such as pricing, delivery schedules, quality control, or any other relevant terms and conditions. For more information or inquiries, please contact Denise Taubman at DENISE.TAUBMAN@DLA.MIL or 2157378677.
    MODIFICATION TO ENALAPRIL NATIONAL CONTRACT
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE - DEFENSE LOGISTICS AGENCY is seeking a modification to the ENALAPRIL NATIONAL CONTRACT. This modification aims to incorporate additional clauses into the existing contract. The ENALAPRIL NATIONAL CONTRACT is typically used for the procurement of enalapril, a medication used to treat high blood pressure and heart failure. The modification will ensure that the contract includes all necessary terms and conditions for the procurement of enalapril. For more information, please contact Denise Taubman at DENISE.TAUBMAN@DLA.MIL or 215-737-8677.
    Fluconazole - SPE2D221-D-0125-P00012 - Final Option Notice
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), has issued a special notice regarding the contract modification for Fluconazole under contract number SPE2D221-D-0125-P00012. This modification announces the exercise of the final option for the procurement of this pharmaceutical product, which is critical for various medical applications within military healthcare. Interested parties can reach out to the primary contact, Courtney Hunter-Stangler, at Courtney.Hunter-Stangler@dla.mil or by phone at 215-737-6845, or to the secondary contact, Jason Wray, at jason.wray@dla.mil or 215-737-0614, for further details regarding this opportunity.
    Fexofenadine HCL Follow On MOD P00002
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE - DEFENSE LOGISTICS AGENCY is seeking Fexofenadine HCL Follow On MOD P00001. Fexofenadine HCL is a drug used to relieve symptoms of seasonal allergies such as runny nose, sneezing, itchy or watery eyes, and itching of the nose or throat. This procurement is for NDC changes. For more information, please contact Catherine Gilbert at catherine.gilbert@dla.mil or 2157374778.
    MODIFICATION TO CONTRACT
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is modifying a contract with DLA TROOP SUPPORT. The modification to the contract is the focus of this notice.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used to treat high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The solicitation will be posted on the DLA Bid Board System and beta.SAM.gov, with a projected solicitation date in June 2021. Interested parties should contact Christopher Newman for more information.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the procurement of Verapamil Hydrochloride (HCL) Tablets, aimed at establishing a contract for the supply of this pharmaceutical product through the VA and Department of Defense Pharmaceutical Prime Vendor Programs. The solicitation requires bidders to provide pricing for the base year and four option years, ensuring compliance with current Good Manufacturing Practices (cGMP) and adherence to FDA regulations, including drug registration and barcoding requirements. This procurement is crucial for maintaining the supply of essential medications for VA healthcare needs. Interested parties must submit their offers by December 24, 2024, at 2:30 PM CST, and can direct inquiries to Contract Specialist Nicholas I. McGregor at Nicholas.McGregor@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0099 770-25-1-801-0137 -National CMOP FENOFIBRATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate Pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP), under solicitation number 36C77025Q0099. The procurement requires multiple quantities of Fenofibrate 145MG 90CT, with specific delivery to various CMOP facilities across the United States, emphasizing compliance with the Buy American statute. This initiative is crucial for ensuring the availability of essential pharmaceuticals for veterans, reflecting the VA's commitment to providing timely medical supplies. Interested vendors must submit their proposals by December 30, 2024, at 09:00 AM CST, including a signed SF1449 cover page, a detailed price schedule in Excel format, proof of state wholesale distributor licensure, and a completed Buy American certificate, with all submissions directed to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    MODIFICATION TO CONTRACT
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE - DEFENSE LOGISTICS AGENCY - DLA TROOP SUPPORT This notice is a modification to a contract and aims to incorporate contract clauses. The service/item being procured is not explicitly mentioned in the document. However, based on the information provided, it can be inferred that the procurement is related to the Department of Defense's logistics support for troop operations. The modification to the contract suggests that there may be changes or additions to the terms and conditions of the existing contract. The primary contact for this procurement is Denise Taubman, who can be reached at denise.taubman@dla.mil or 2157376877.